ロード中...
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
OBJECTIVES: To evaluate clinical remission with subcutaneous abatacept plus methotrexate (MTX) and abatacept monotherapy at 12 months in patients with early rheumatoid arthritis (RA), and maintenance of remission following the rapid withdrawal of all RA treatment. METHODS: In the Assessing Very Earl...
保存先:
| 出版年: | Ann Rheum Dis |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4283672/ https://ncbi.nlm.nih.gov/pubmed/25367713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2014-206106 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|